Search

everythinglearnresearchcommunity

for

Search:↓

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Hair loss linked to higher heart disease risk in both men and women.

Spironolactone plus finasteride reduces hirsutism more effectively.

Finasteride and metformin both help treat PCOS, but using them together works best.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Diane 35 plus finasteride is more effective for treating hirsutism.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Hidradenitis suppurativa improves with antiandrogen therapy.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Suppressing certain hormones might help prevent prostate cancer.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.